MTNB Earnings

MTNB reported its earnings on 2026-03-09, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 4.72% price change on the earnings day and a 33.96% change over the next five days, reflecting market reactions to the results.

Following MTNB's earnings announcement on 2026-03-09, the stock price moved by 4.72% on the day of the release. Over the subsequent five days, it saw a 33.96% change. Historically, MTNB's stock price tends to shift by an average of -11.8% in the 10 days leading up to earnings and -11.68% in the 10 days following, providing insight into potential market.

For , analysts estimate MTNB's annual revenue to reach undefined, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised downward by -17.57% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MTNB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised downward by -17.57%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MTNB's stock price typically moves by -11.8% in the 10 days before its earnings and -11.68% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of undefined.

The earnings call reveals several negative factors: declining revenue, increased net loss, and limited cash reserves, which could hinder operations. The success of MAT2203 is critical, yet dependent on securing a strategic partner and trial success, both uncertain. The competitive market and pricing challenges add further risk. Although there are potential opportunities in cytokine targeting, management's vague responses on partnerships and specific targets raise concerns. Overall, these issues outweigh the positive aspects, leading to a negative sentiment.